CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (1,130,281)	$ (3,844,246)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	298,951	338,918
Gain on sale of property and equipment		(6,083)
Unrealized (gain) loss on change in fair value of warrants classified as a liability	(2,639,000)	2,637,800
Stock-based compensation	340,705	93,748
Change in provision for bad debts		(290,022)
Change in operating assets and liabilities:
Accounts receivable	(195,254)	(695,912)
Inventories	(47,264)	125,230
Prepaid expenses, other current assets and deposits	(13,712)	133,374
Accounts payable and accrued liabilities	(383,423)	(586,236)
Deferred revenue	11,599	(289,677)
Net cash used in operating activities	(3,757,679)	(2,383,106)
Cash flows from investing activities:
Proceeds from sale of property and equipment		45,000
Net cash used in investing activities		45,000
Cash flows from financing activities:
Net proceeds from issuance of common stock	45,566
Capitalized transaction costs	(80,642)
Net cash used in financing activities	(35,076)
Net decrease in cash, cash equivalents and restricted cash	(3,792,755)	(2,338,106)
Cash, cash equivalents and restricted cash at beginning of period	7,901,800	15,215,285
Cash, cash equivalents and restricted cash at end of period	4,109,045	12,877,179
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest	0	0
Cash paid during period for income taxes	0	0
Non-cash investing and financing activities:
Capitalized transaction costs included in accounts payable	136,911
Deemed dividend warrant modifications	$ 77,757
Property and equipment acquired and included in accounts payable		$ 20,619